![](https://sourceonhealth.wpenginepowered.com/wp-content/uploads/2019/04/SLIHCQ-title-1.png)
HB 296 – Maryland
Status: Inactive / DeadYear Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb0296&stab=01&pid=billpage&tab=subject3&ys=2019RS
Requiring, at the point of sale, a certain pharmacist or the pharmacist’s designee to inform a retail consumer, to the best of the pharmacist’s or pharmacist’s designee’s knowledge, of the retail price for a prescription drug and, under certain circumstances, the cost share for which the retail consumer is responsible for the prescription drug; and requiring the State Board of Pharmacy to adopt certain procedures.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found